ACADIA PHARMACEUTICALS A/S: Financial statements 2024
CVR: 19670694
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -99,365 compared with DKK -151,395 the year before. Equity in the 2024 report amounted to DKK -1,092,137.
- Profit/Loss
- DKK -99,365
- Equity
- DKK -1,092,137
- Total Assets
- DKK 54,553
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -99K | -1.1M | 0 |
| 2023 | - | -151K | -151K | -993K | 0 |
| 2022 | - | -254K | -254K | -841K | 0 |
| 2021 | - | -21K | -21K | -588K | 0 |
| 2020 | - | - | -57K | -567K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ACADIA PHARMACEUTICALS A/S has published its annual report for 2023. Gross profit came to DKK -151,395, and the net result was DKK -151,395.
As of May 2, 2024, Jennifer Jane Rhodes has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Peter Francis Chae has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Austin Kim has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Jennifer Jane Rhodes is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Austin Kim has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.